Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

January 31, 2014

Conditions
Glioblastoma
Interventions
DRUG

cediranib maleate

DRUG

gefitinib

DRUG

Placebo

Trial Locations (10)

NW1 2BU

University College Hospital, London

Unknown

Queen Elizabeth Hospital, Birmingham

Bristol Haematology and Oncology Centre, Bristol

Addenbrooke's Hospital, Cambridge

Royal Surrey County Hospital, Guildford

Castle Hill Hospital, Hull

Charing Cross Hospital, London

The Christie NHS Foundation Trust, Manchester

Southampton General Hospital, Southampton

Royal Marsden Hospital, Sutton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University College, London

OTHER